Editorial Policies

The International Journal of Pharmaceutical Research and Biomedical Analysis (IJPRBA) is committed to upholding the highest standards of publication ethics, integrity, and transparency, following the guidelines established by the Committee on Publication Ethics (COPE). The journal ensures a fair and rigorous peer-review process, ethical research practices, and unrestricted access to scientific knowledge.

  1. Peer Review Process
  • The journal follows a double-blind peer review process to ensure objectivity and fairness.
  • Manuscripts are reviewed by at least two independent experts in the field.
  • Reviewers and authors remain anonymous to each other to prevent bias.
  • The final decision on publication rests with the Editor-in-Chief, based on reviewers’ recommendations and compliance with journal guidelines.
  1. Authorship and Contribution
  • Authors must meet the criteria established by the ICMJE (International Committee of Medical Journal Editors), which include:
    • Substantial contributions to the study conception, design, data collection, or analysis.
    • Drafting or critically revising the manuscript.
    • Final approval of the version to be published.
    • Agreement to be accountable for all aspects of the work.
  • All authors must disclose their specific contributions in the manuscript.
  • Ghostwriting, guest authorship, or honorary authorship is strictly prohibited.
  1. Ethical Considerations in Research
  • Authors must comply with ethical guidelines, including:
    • Human and animal research: Studies involving human subjects must have approval from an Institutional Ethics Committee (IEC) and comply with the Declaration of Helsinki. Animal studies must follow guidelines from relevant regulatory bodies.
    • Informed consent: Authors must obtain written informed consent from human participants before conducting research.
    • Clinical trials: Must be registered in a publicly accessible trial registry (e.g., ClinicalTrials.gov).
  1. Plagiarism and Academic Misconduct
  • The journal strictly prohibits plagiarism, fabrication, falsification, and redundant publication.
  • All submissions are checked for plagiarism using reliable plagiarism detection software.
  • If plagiarism is detected, the manuscript will be rejected, and appropriate actions will be taken following COPE guidelines.
  1. Conflicts of Interest
  • Authors, reviewers, and editors must disclose any financial, institutional, or personal conflicts of interest that may influence the research or review process.
  • If conflicts of interest are found post-publication, corrective measures such as retractions or corrections may be taken.
  1. Data Availability and Transparency
  • Authors should provide raw data, protocols, and supplementary materials upon request.
  • Research data must be accurately reported, reproducible, and free from manipulation.
  1. Retractions, Corrections, and Expressions of Concern
  • The journal follows COPE guidelines for handling erroneous or unethical publications:
    • Corrections: Minor errors that do not affect the study's conclusions will be corrected through an erratum or corrigendum.
    • Retractions: If a study is found to have serious ethical violations, fabrication, or falsification, it will be retracted with a formal statement explaining the reasons.
    • Expressions of Concern: If there are unresolved ethical issues under investigation, a statement will be published until a final decision is reached.
  1. Copyright and Open Access Policy
  • The journal follows an open-access model, ensuring that all published content is freely available under the Creative Commons Attribution-NonCommercial-ShareAlike(CC-BY-NC-SA) License.
  • Authors retain copyright but grant the journal the right to publish, distribute, and archive the manuscript.
  • Appeals and Complaints
  • Authors who believe their manuscript was unfairly rejected may submit a formal appeal, providing clear justifications.
  • Complaints about ethical breaches or editorial decisions should be addressed to the Editor-in-Chief, who will investigate following COPE’s dispute resolution guidelines.

By submitting to IJPRBA, authors agree to adhere to these editorial policies and maintain the highest ethical standards in scientific publishing.